IL Group Previews Packaging Safety Solutions to be Shown at INTERPHEX

Japan-based IL Group, whose United States entity is Iwata Label USA, has announced several of the solutions it will be showcasing at INTERPHEX 2025, which is being held April 1–3, 2025 at the Javits Center in New York City (1).

In a March 10, 2025 press release previewing the company’s offerings at the annual conference, IL Group mentioned three products it would be spotlighting:

• The Vial Protect Pack series is designed to give additional protection to fragile or high-leverage glass vials, and outer surface contamination of cytoxic medicine, according to IL Group (1). The series is available in two configurations, Vial Protect Pack I, which has a bottom plastic plate attached to the vial with a Shrink Tack Label for enhanced protection, and Vial Protect Pack II, which IL Group describes as a “container for a container,” combining a plastic cup to cradle the primary vial along with a label for reliable tamper evidence.
• The Shrink Tack Label, as referenced above, is designed for tamper-evident sealing intended to secure syringe contents and prevent tip cap movement in the process of shipping (1). IL Group said this brings documentation, sealing, and tamper evidence into a singular, streamlined process.

• IL Group’s Light Protect Pack, meanwhile, maintains drug stability by blocking light via wavelengths as low as 380 nanometers (violet), but with material (amber) as low as 500 nanometers available (1). This solution, the company said, is successful at shielding light for applications using clear glass vials or either glass or plastic syringes.

“We are excited to present our latest advancements in pharmaceutical labeling at INTERPHEX 2025,” said Eiji Funabashi, president, Iwata Label USA, in the press release. “Our Vial Protect Pack, Light Protect Pack, and tamper-evident solutions for syringes are designed to meet the highest industry standards, ensuring safety for healthcare personnel and patients, as well as regulatory compliance and operational efficiency for pharmaceutical manufacturers.”

Looking at advancements in packaging solutions, specifically with regard to vial innovations, Pharmapack Europe announced winners of its annual Pharmapack Awards in January 2025. Japan-based Mitsubishi Gas Chemical won in the Packaging Innovation category for a new vial, the OXYCAPT Multilayer Plastic Vial, designed to store gene therapy products using dry ice and liquid nitrogen (2). OXYCAPT provides an oxygen (O2), carbon dioxide (CO2), and ultraviolet (UV) barrier 20 times better than standard cyclic olefin polymer monolayer vials, according to Pharmapack’s press release announcing the awards.

“This year [2024], we’ve seen a record number of award categories, yet the quality and innovation of entries continue to reach new heights. Notably, many submissions demonstrate a strong commitment to advancing sustainability through reduced raw material usage, improved recyclability, and lower carbon footprints, all while enhancing patient and user experiences,” said Tara Dougal, brand and content director—Pharma, at Informa, in the press release (2). “These efforts reflect the industry's determination to address critical challenges and shape the future of healthcare. We applaud the entire pharma packaging and drug delivery sector for its relentless drive toward innovation and transformative care standards.”

For more coverage of INTERPHEX, please visit this link.

References

1. IL Group. At INTERPHEX NYC, IL Group to Exhibit Containment and Light Protection Solutions for Vials, and Safety Label with Tamper Evidence for Syringes. Press Release. March 10, 2025.
2. Pharmapack Europe. Pharmapack Award Winners 2025 Redefining Pharmaceutical Packaging and Drug Delivery. Press Release. Jan. 22, 2025.